Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 5, 1997, Pages 640-647

  Petsrsen, Lars J ^a,d   Church, Martin K ^c   Skov, Per S ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b RefLab   (Denmark)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

histamine release; human; microdialysis; Platelet activating factor; skin

Indexed keywords

BICARBONATE; CAPSAICIN; HISTAMINE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; DIALYSIS; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MAST CELL; NERVE BLOCK; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; URTICARIA;

EID: 0030974298     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70026-5     Document Type: Article

References (37)

1. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
2. Mencia-Huerta JM, Hosford D, Braquet P. Acute and long-term pulmonary effects of platelet-activating factor. Clin Exp Allergy 1989;19:125-42.
3. Basran GS, Page CP, Paul W, Morley J. Cromoglycate (DSCG) inhibits responses to platelet-activating factor (Paf-acether) in man: an alternative mode of action for DSCG in asthma? Eur J Pharmacol 1983;86:143-4.
4. 1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol 1985;85:109-13.
5. Fjellner B, Hägermark Ö. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta Derm Venereol Stockh 1985;65:409-12.
6. Chung KF, Minette P, McCusker M, Barnes PJ. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. J Allergy Clin Immunol 1988;81:1192-211.
7. McCusker MT, Chung KF, Roberts NM, Barnes PJ. Effect of topical capsaicin on the cutaneous responses to inflammatory mediators and to antigen in man. J Allergy Clin Immunol 1989;83:1118-24.
8. Fadel R, David B, Herpin-Richard N, Borgnon A, Rassemont R, Rihoux JP. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man. J Allergy Clin Immunol 1990;86:314-20.
9. Sciberras DG, Jordan S, Gill D, Baber NS, James I. The role of histamine in the acute inflammatory responses to intradermal platelet activating factor. Br J Clin Pharmacol 1991;32:85-90.
10. Thomas G, Church MK. Platelet activating factor does not release histamine from human dispersed cutaneous mast cells. Clin Exp Allergy 1990;20:377-82.
11. Columbo M, Casolaro V, Warner JA, MacGlashan DW Jr, Kagey-Sobotka A, Lichtenstein LM. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol 1990;145:3855-61.
12. Henocq E, Vargaftig BB. Skin eosinophilia in atopic patients. J Allergy Clin Immunol 1988;81:691-5.
13. Petersen LJ, Kristensen JK, Bülow J. Microdialysis of the interstitial water space in human skin in vivo: quantitative measurement of cutaneous glucose concentrations. J Invest Dermatol 1992;99:357-60.
14. Petersen LJ, Poulsen LK, Soøndergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994;94:773-83.
15. Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM. Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol 1995;95:565-73.
16. Okuda Y, Tsuyuguchi I, Yamatodani A. Histamine release from human leukocytes by platelet-activating factor. Int Arch Allergy Appl Immunol 1988;85:341-5.
17. Michel L, Mencia-Huerta JM, Benveniste J, Dubertret L. Biologic properties of LTB4 and paf-acether in vivo in human skin. J Invest Dermatol 1987;88:675-81.
18. Petersen LJ, Brasso K, Pryds M, Skov PS. Histamine release in intact human skin by monocyte chemoattractant factor-1, RANTES, macrophage inflammatory protein-1α, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J Allergy Clin Immunol 1996;98:790-6.
19. Tainsh KR, Liu WL, Lau HY, Cohen J, Pearce FL. Mast cell heterogeneity in man: unique functional properties of skin mast cells in response to a range of polycationic stimuli. Immunopharmacology 1992;24:171-80.
20. Petersen LJ, Nielsen HJ, Skov PS. Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy 1995;25:1045-52.
21. Bussolino F, Camussi G, Aglietta M, et al. Human endothelial cells are target for platelet-activating factor: I-platelet-activating factor induces changes in cytoskeleton structures. J Immunol 1987;139:2439-46.
22. Tomeo AC, Egan RW, Duran WN. Priming interactions between platelet activating factor and histamine in the in vivo microcirculation. FASEB J 1991;5:2850-5.
23. Kornecki E, Lenox RH, Hardwick DH, Bergdahl JA, Ehrlich YH. Interactions of the alkyl-ether-phospholopid, platelet activating factor (PAF) with platelets, neural cells, and the psychotrophic drugs triazolobenzodiazepines. Adv Exp Med Biol 1987;221:477-88.
24. Kornecki E, Ehrlich YH. Neuroregulatory and neuropathological actions of the ether-phospholopid platelet-activating factor. Science 1988;240:1792-4.
25. Willard AL. Excitatory and neurotoxic actions of platelet-activating factor on rat myenteric neurons in cell culture. Ann N Y Acad Sci 1992;664:284-92.
26. Shigenobu K, Mori T, Kamata K, Kasuya Y. Platelet-activating factor: lack of direct action on guinea pig myocardium and possible transmitter release from cardiac sympathetic nerve endings at high concentrations. Can J Physiol Pharmacol 1989;67:669-74.
27. Spina D, McKenniff MG, Coyle AJ, et al. Effect of capsaicin on PAF-induced bronchial hyperresponsiveness and pulmonary cell accumulation in the rabbit. Br J Pharmacol 1991;103:1268-74.
28. Peretti F, Manzini S. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs. Am Rev Respir Dis 1993;148:927-31.
29. Foreman J, Jordan C. Histamine release and vascular changes induced by neuropeptides. Agents Actions 1983;13:105-16.
30. Lowman MA, Benyon RC, Church MK. Characterization of neu-ropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988;95:121-30.
31. Bewley AP, Skinner S, Petersen LJ, Keefe M, Church MK. Vasoactive intestinal peptide (VIP) induced histamine release from human cutaneous mast cells in vivo [Abstract]. Skin Pharmacol 1995;9:143-4.
32. Lynn B. Neurogenic inflammation. Skin Pharmacol 1988;1:217-24.
33. Blennerhassett MG, Janiszewski J, Bienenstock J. Sympathetic nerve contact alters membrane resistance of cells of the RBL-2H3 mucosal mast cell line. Am J Respir Cell Mol Biol 1992;6:504-9.
34. Stoll LL, Figard PH, Yerram NR, Yorek MA, Spector AA. 1-0-alkyl2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells. Cell Regul 1989;1:13-25.
35. Barr RM, Lawlor F, Judge MR, et al. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. Br J Clin Pharmacol 1993;35:637-41.
36. Michel L, De Vos C, Rihoux JP, Burtin C, Benveniste J, Dubertret L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988;82:101-9.
37. Shalit M, Valone FH, Atkins PC, Ratnoff WD. Goetzl EJ, Zweiman B. Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 1989;83:691-6.